Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

03/24/10 Move Triggered Medicare Review, Loss of Coverage, Return of Cancer (11 year GBM survivor)        

03/24/10 Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study.        

03/23/10 Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.        

03/19/10 Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.        

03/19/10 Is aspartame safe?        

03/19/10 The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma.        

03/17/10 Lycopene in treatment of high-grade gliomas: A pilot study.        

03/16/10 IBTA E-News March 2010        

03/16/10 New Brain Tumor Videos Added to Virtualtrials.com        

03/16/10 University of Rochester Medical Center hosts Brain Tumor Awareness Week events        

03/15/10 Talking With Your Children About Brain Tumors -- A Seminar in Long Branch, NJ        

03/14/10 Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers        

03/13/10 Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.        

03/13/10 New York Presbyterian Hospital - New support group        

03/13/10 Swedish Neuroscience Institute (in Seattle, Wash.) Brain Cancer Surgeon Publishes Major Feature Article in Scientific American MIND        

03/10/10 ImmunoCellular Therapeutics' Dendritic Cell-Based Vaccine Demonstrates Statistically Significant Increase in Survival in an Animal Model of Glioblastoma        

03/09/10 Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma.        

03/05/10 Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).        

02/28/10 Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinib.        

---

Displaying Stories 3150 to 3169 of 7806
Previous 20           Next 20